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MaKeaOHCKO 3apYJKeHUe 3a KpUmUIIHO 60nHu na~UeHmU, MaKeaOHCKO 3apYJKeHUe 3a 
aHeCme3uonozuja, MaKeaOH3KO 3apYJKeHUe 3a mpaHCrPY3UOHa MeaU~UHa nOa nampOHam Ha 
HATA 
Isa MAKEAOHCKA KOHCl>EPEHl~lI1JA 3A AnTEPHATlI1BlI1 BO 

TPAHCCl>Y3111JATA KAJ KPlI1TlI1l1HO EiOnHlI1 nA~lI1EHTlI1 
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KYCM M3BA,D,OlJ,M O,D, nPE,D,ABAI-bATA 
I MaKeAOHCKa KOHct>epeH4Hja 3a anTepHaTHBH BO TpaHCct>V3HjaTa Kaj KPHTH"IHO 60J1HH na4HeHTH 
oco6eHO 3HaejKIII ,o,eKa BO nOC11e,o,HO BpeMe K011Ii1YIiIHl1Te Ha KpBH I.1 ep,IiIHIII I..\IiI ce HaMaJleHIII , 3HaejKIII 
,[I8Ka He CTe 3aBIIICHlil 0,0, ,o,pyr , 0,0, ,o,OHlllpaHa KpB 0,0, ,o,aplIITe11111 Ha KPB, a nplIIToa He 1113110>KYBajKIiI r ill 
nal.\lIIeHHne Ha 6 111110 KaKBa onaCHOCT 0,0, IiIHcpeKl..\ lII111 III aneprlll III , YWTe nos e Ke ro IIIcTaKHYBaaT 
3Ha48tbeTO Ha aYToTp aHccpY3Y1jaTa. 
1. 	 LlOnaHyeCKVl B., KOHAOB r.- EKcTpaKOpnOpaJlHa 4l-1PKYJla 4Io1ja. 1995 Kymypa, CKonje. 
2. 	 Page P., Perioperati ve autotransfusion and its core lation to hemostasi s and coagulopa ties.- The journal of extracorporeal 
tehnology. vol 23. N 1. p14- 2l. 
3. 	 Anders Bengtsson -Pros and Cons with Autotransfusion Devi ces ., Gbteborg, Sweden, September 28, 2001. 
4. 	 David Bregman, M.D., Eduardo N. Pa rodi, M.D.,John E. Hutchinson, 111, M.D., Keith Reemtsma, M.D.,and James R. Maim, M.D. 
Intraoperative Autotransfusion During Emergency Thoracic and ElectiveOpen-Heart Surgery-Ann Thorac Surg 1974; 18: 590-596. 
ANAESTHESIOLOGIC STRATEGIES,METHODS AND TECHNIQUES FOR REDUCNG THE 
PERIOPERATIVE BLOOD LOSS / NEEDS OF HEMOTRANSFUSION 
P. Tou rl akov, S. Georgiev 
Sofija, R Bu lgaria 
The theme for adequate and precise peri-operative blood use is becoming more and more actual in the aspect 
of the increasing number of operative procedures, the limited resources of blood and blood products and t he 
growing threat of tra nsmissive infections. 
Together with the soph istication of pure surgical methods, a broad spectrum of other tech niques are applied in 
the peri-operative period during anaesth esia/surgery as in the intensive care units. These techniques are charac­
terized with their accessibility and relatively low cost of tech nica l devices and materials. For the correct appli­
cation of most of them a perfect organization and precise collaboration between the responsible su rgical and 
anaesthesia/int ensive care teams is needed. 
Most of these methods are applied for long time and are well known-acute normovolemic hemodilutio n, in­
fusion therapy, controlled hypotension, others became important with the development of modern devices and 
methods for sparing of blood and blood prod ucts-autohemotransfusion and intra-operative re infusion. 
Here we shall present the preliminary results of a pilot study including 20 fema le patients subjected to radical 
hysterectomy. The main aim is to combine the most effective methods and techniques in 3 most adequate 
peri-operative anaesthesia and Intensive care management protocol for that category of pati ents. 
RATIONAL USE OF BLOOD AND BLOOD PRODUCTS IN CARDIO SURGERY 
Zan Mit rev, T.Anguseva, E Ambarkova 
Special Hospi t al for card iosurgery Fillip II , Skopje, R of Macedonia 
Background: Cardiac surgery is associated wit h a high rate of blood transfusion. The ration ale for red blood cell 
(RBe) transfusion is based on the observation that anemia is an independent risk factor for illness and death 
after cardiac operations. However, t ransfusio ns have been associated with high rates of these poor ou.tcomes in 
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critically ill patients, and some recent studies have shown worse outcomes compared with nontransfused patients 
after cardiac surgery. 
Matherial and methods: between March 2000 and October 2012 11 742 adu lt patients had been operated in 
special hospital for cardiac surgery. 3190 patients who underwent cardiac surgery with cardiopulmonary bypass 
during last t hree years had been included in this study. Patients were randomly assigned to a liberal strategy of 
blood transfusion (to maintain a hematocrit [the volume percentage of red blood cells in whole blood] of 30 per­
cent or greater) . The overall average hematocrit values in the ICU were 31.8 percent. 
Results: A tota l of 2488 of 3190 patients (78 percent) received a blood transfusion. The researchers found that 
the primary composite outcome measured at 30 days-death from any cause, cardiogenic shock, acute respi­
ratory distress syndrome, or acute rena l injury requ iring dialysis or hemofiltration during the hospital stay­
occurred in 10 percent of patients. Independent of transfusion strategy, the number of transfused red blood cell 
units was an independent risk factor for clinical complications or death at 30 days. Average usage was 1,5 blood 
per pts, O,7plqsma per pts, 0,1 trombocyte units per pts. All pts who were with antiagregant therapy got ciklo­
kapron before connecting on heart lung machine. 
There were no significant differences in the occurrence of cardiac, respiratory, neurologic, or infectious complica­
tions, or severe bleeding requiring reoperation . There were also no differences in lengths of ICU or hospital stay. 
Conclussion: The authors suggest that the rationale for implementing a restrictive transfusion strategy is based 
on many studies that have shown a lack of benefit and, at the same time, substantially increased costs and ad­
verse effects associated with RBC transfusion, including transmission of viral and bacterial diseases and transfu­
sion-related acute lung injury. 
TRANSFUSION SUPPORT IN HEMATOPOIETIC STEM CELL TRANSPLANTATION 
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Pe3MMe 
AJ10reHaTa TpaHCnJ1aHTal...\lIIja Ha Man14HIiI KJleTKI!1 (TMK) e ycneweH Ha4111H 3a J1eKYBal-be Ha nal...\liIeH­
TIIITe co MaJllllrHIII xeMaTOflOWKIiI 3a6oJ1YBal-ba. TeKoBHIiITe cTaHAapAHIiI npoToKofllil BKflY4yBaaT MaK­
CIIIMaIlHIII A031i1 Ha CIIICTeMCKa xeMopa,qliljaL.\lIIja IiIcToBpeMeHo 3a epa,qIllKal...\liIja Ha KaHl...\epoT iii 3a IIIMy­
~ 	 H0J10WKa cynpeclllja Ha AOMaKlilHoT. 3a BpeMe Ha naHl...\IiIToneH1II4HliloT nepllloA, npaKTIII4HO ceKoj TPaHc­
nnaHTliIpaH nal...\lIIeH IIIMa nOTpe6a oA IiIHTeH31i1BHa TpaHccpY31110J10WKa nOAAPwKa. 
KOHAIIIl...\IiIOHlilpa4KIIIOT npoToKofl, T.e. BIiIAOT Ha MlileflOa6flaTlt1BHaTa Tepanlilja KaKO iii ABO KOMnaTIiI­
611lflHOCTa nOMefy AaplllTefloT III npliIMaTefloT BO rOfleMa MepKa BflllljaaT Ha nOTpe6111Te oA TpaHccpy­
31i1ja (Kofllll4l11Ha III BillA Ha KpBHIII KOMnOHeHTIII). 
ABO IiIHKoMnaT1II61i1J1l11jaTa MO>Ke Aa 611lAe MajopHa, MIIIHopHa, iii ABojHa, BO 3aBIiICHOCT oA nplilcycTBO­
TO Ha 1Il30XeMarnyrlllHIIlHIiI Kaj npliIMaTeflOT YCMepeHIII npOTlilB aHTWeHIIITe Ha ept.-np0l...\IIITIiITe OA Aa­
pIIITeJ10T. OKOflY 20 AO 25% oA TMK ce co MajopHa 1IlJ11i1 MIiIHopHa IIIHKoMnaT1iI61i1J1ja, AOAeKa 5% ce 
co ABojHa ABO IiIHKoMnaTlII6li1fllllja. CeKoja oA HIiIB ce KapaKTeplil31i1pa co Cnel...\liIcplil4HIII IIIMyHoxe­
MaTOflOWKIil HaoAIiI III nOTeHl...\lIljaflHIIl HecaKaHIil ecpeKTIIl KaKO WTO e aKyrHa X9MOfllllTIIl4Ka p9aKl...\IiI­
ja, O,q.nO>K9HO nplllcpaKal-b9 Ha rpacpToT iii nocT-TPaHCnIlaHTaL.\liIoHa eplIITpoyl4THa anfla3111ja WTO nplll­
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